ENAGenomicsINSERM U1170, Paris, France Gustave Roussy Institute, Villejuif, France Université Paris Saclay, FranceEuropean Bioinformatics Institutehttps://www.ebi.ac.uk/ena/browser/view/PRJEB76805ArrayExpressCBFA2T3::GLIS2 was fused with GFP through CRISPR-Cas9 in WSU-AML cells. Cells were then used for ChIP-seq using a GFP antibody in order to determined the CBFA2T3::GLIS2 fusion binding sites.ENAfalseChIP-seq to identify binding sites of the fusion oncogene CBFA2T3::GLIS2 in WSU-AML cell lineChIP-seq to identify binding sites of the fusion oncogene CBFA2T3::GLIS2 in WSU-AML cell line2025-07-092025-07-09PRJEB76805